Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Chiasma Inc (CHMA)

Chiasma Inc (CHMA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 217,681
  • Shares Outstanding, K 57,894
  • Annual Sales, $ 1,110 K
  • Annual Income, $ -74,780 K
  • 60-Month Beta 1.28
  • Price/Sales 209.38
  • Price/Cash Flow N/A
  • Price/Book 3.47
Trade CHMA with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.61
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/09/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview

Details
  • Implied Volatility 0.00%
  • Historical Volatility 42.39%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.32
  • Number of Estimates 3
  • High Estimate -0.31
  • Low Estimate -0.35
  • Prior Year -0.50
  • Growth Rate Est. (year over year) +36.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.76 unch
on 08/05/21
4.72 -20.34%
on 07/06/21
-0.95 (-20.17%)
since 07/02/21
3-Month
3.70 +1.62%
on 05/06/21
4.93 -23.73%
on 06/25/21
-0.22 (-5.53%)
since 05/05/21
52-Week
2.77 +35.74%
on 03/29/21
5.74 -34.49%
on 09/14/20
-0.97 (-20.51%)
since 08/05/20

Most Recent Stories

More News
Pulmatrix appoints Director Anand Varadan

/PRNewswire/ --  (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™...

PULM : 0.7726 (-0.05%)
CHMA : 3.76 (-6.00%)
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates RAVN, BOCH, ONEM, CHMA; Shareholders are Encouraged to Contact the Firm

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

RAVN : 57.43 (-0.30%)
BOCH : 13.12 (unch)
ONEM : 23.71 (-6.14%)
CHMA : 3.76 (-6.00%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds ONEM, BOCH, CHMA, and QTS Shareholders About Its Ongoing Investigations

/PRNewswire/ --

ONEM : 23.71 (-6.14%)
BOCH : 13.12 (unch)
CHMA : 3.76 (-6.00%)
QTS : 77.98 (+0.04%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates WRI, WBT, CHMA, XOG, USCR, ONEM; Shareholders are Encouraged to Contact the Firm

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

ONEM : 23.71 (-6.14%)
WRI : 31.44 (-2.06%)
WBT : 23.49 (-0.17%)
CHMA : 3.76 (-6.00%)
XOG : 51.49 (-2.24%)
USCR : 73.99 (-0.01%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds ONEM, BOCH, CHMA, and MDCA Shareholders About Its Ongoing Investigations

/PRNewswire/ --

ONEM : 23.71 (-6.14%)
BOCH : 13.12 (unch)
CHMA : 3.76 (-6.00%)
MDCA : 5.42 (-3.39%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates ONEM, SYKE, NETE, CHMA, SOLY, ARPO; Shareholders are Encouraged to Contact the Firm

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

ONEM : 23.71 (-6.14%)
SYKE : 54.00 (+0.04%)
NETE : 9.29 (-0.75%)
CHMA : 3.76 (-6.00%)
SOLY : 21.21 (-0.66%)
ARPO : 2.20 (-0.90%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds BOCH, PLBN, CORE, and CHMA Shareholders About Its Ongoing Investigations

/PRNewswire/ --

BOCH : 13.12 (unch)
PLBN : 6.0500 (-0.82%)
CORE : 45.65 (-0.76%)
CHMA : 3.76 (-6.00%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates HGV, CHMA, ONDS, BOCH; Shareholders are Encouraged to Contact the Firm

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

HGV : 46.48 (+0.74%)
CHMA : 3.76 (-6.00%)
ONDS : 8.26 (+12.38%)
BOCH : 13.12 (unch)
SHAREHOLDER ALERT: WeissLaw LLP Reminds BOCH, PLBN, CORE, and CHMA Shareholders About Its Ongoing Investigations

/PRNewswire/ --

BOCH : 13.12 (unch)
PLBN : 6.0500 (-0.82%)
CORE : 45.65 (-0.76%)
CHMA : 3.76 (-6.00%)
Chiasma Announces Submission of Marketing Authorization Application for MYCAPSSA(R) to the European Medicines Agency

Chiasma, Inc. (NASDAQ: CHMA), ("Chiasma" or the "Company"), a commercial-stage biopharmaceutical company utilizing its delivery platform technology to develop and commercialize oral therapies to improve...

CHMA : 3.76 (-6.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Chiasma, Inc. is a biopharmaceutical company. The company's TPE(R) technology develops oral peptides and other molecules. Its primary product candidate consists of oral octreotide which is in different clinical trial. Chiasma, Inc. is based in Newton, USA.

See More

Key Turning Points

3rd Resistance Point 4.33
2nd Resistance Point 4.21
1st Resistance Point 3.99
Last Price 3.76
1st Support Level 3.65
2nd Support Level 3.53
3rd Support Level 3.31

See More

52-Week High 5.74
Fibonacci 61.8% 4.61
Fibonacci 50% 4.26
Fibonacci 38.2% 3.90
Last Price 3.76
52-Week Low 2.77

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar